Edesa Biotech Inc

General ticker "EDSA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $11.4M (TTM average)

Edesa Biotech Inc does not follow the US Stock Market performance with the rate: -26.6%.

Estimated limits based on current volatility of 2.8%: low 2.25$, high 2.38$

Factors to consider:

  • Current price 26.5% below estimated low
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

  • 2024-09-30 to 2025-09-30 estimated range: [3.18$, 8.88$]
  • 2025-09-30 to 2026-09-30 estimated range: [2.13$, 6.25$]

Financial Metrics affecting the EDSA estimates:

  • Negative: Non-GAAP EPS, $ of -1.93 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -25.81 <= 1.79
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Industry earnings per price (median), % of -32.02 <= 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: 43.26 < Shareholder equity ratio, % of 51.94 <= 63.75
  • Negative: negative Operating income
  • Negative: Industry operating cash flow per share per price (median), % of -24.48 <= 2.82

Similar symbols

Short-term EDSA quotes

2025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162.12.22.32.42.52.6
Price $

Long-term EDSA plot with estimates

246810Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026−0.6−0.4−0.20
EDSAS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-09-30 2023-09-30 2024-09-30
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $18.37MM $9.22MM $7.01MM
Operating Income $-18.37MM $-9.22MM $-7.01MM
Non-Operating Income $0.82MM $0.85MM $0.85MM
R&D Expense $13.34MM $4.79MM $2.88MM
Income(Loss) $-17.55MM $-8.37MM $-6.17MM
Taxes $0.00MM $0.00MM $0.00MM
Profit(Loss)* $-17.55MM $-8.37MM $-6.17MM
Stockholders Equity $9.39MM $7.05MM $1.98MM
Inventory $1.26MM $0.00MM $0.00MM
Assets $11.58MM $8.89MM $3.81MM
Operating Cash Flow $-12.28MM $-6.64MM $-4.89MM
Capital expenditure $0.01MM $0.00MM $0.00MM
Investing Cash Flow $-0.01MM $0.00MM $-0.03MM
Financing Cash Flow $11.63MM $4.83MM $0.59MM
Earnings Per Share** $-8.37 $-2.93 $-1.93

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.